Neil A O'Brien Selected Research

Neil A O'Brien Research Topics

Disease

16	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2005
9	Neoplasms (Cancer) 01/2022 - 04/2005
1	Disease Progression 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 05/2013
1	Stomach Neoplasms (Stomach Cancer) 04/2013
1	Fibroadenoma 04/2005

Drug/Important Bio-Agent (IBA)

13	Trastuzumab (Herceptin)FDA Link 01/2022 - 06/2010
4	Tyrosine Kinase InhibitorsIBA 02/2019 - 12/2012
4	Lapatinib (GW572016)FDA Link 10/2018 - 06/2010
3	Hormones (Hormone)IBA 01/2020 - 04/2005
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2018 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2005
2	Tamoxifen FDA LinkGeneric 06/2017 - 02/2015
1	tucatinibIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Aldehyde DehydrogenaseIBA 01/2020
1	AlpelisibIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	pertuzumabIBA 01/2019
1	AfatinibIBA 01/2019
1	obatoclaxIBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2018
1	Everolimus FDA Link 02/2015
1	exemestane (Aromasin)FDA Link 02/2015
1	Fulvestrant (Faslodex)FDA Link 02/2015
1	Phenobarbital (Luminal)FDA Link 02/2015
1	benthiocarb (Bolero)IBA 07/2014
1	neratinibIBA 10/2013
1	infigratinibIBA 05/2013
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 05/2013
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2013
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 05/2013
1	Pharmaceutical PreparationsIBA 04/2013
1	dacomitinibIBA 09/2012
1	Epidermal Growth Factor (EGF)IBA 09/2012
1	ErbB Receptors (EGF Receptor)IBA 09/2012
1	LigandsIBA 09/2012
1	human ERBB2 proteinIBA 06/2010
1	Mammaglobin AIBA 04/2005

Therapy/Procedure

11	Therapeutics 01/2022 - 06/2010
1	Drug Therapy (Chemotherapy) 06/2017